Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

IlAcrLepo

ABSTRACT: Acronicta leporina (the miller)

PROVIDER: PRJEB56406 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other
	ERR10313053_1.fastq.gz	Fastqsanger.gz
	ERR10313053_2.fastq.gz	Fastqsanger.gz
	ERR10357391.fastq.gz	Fastqsanger.gz
	ERR11606287_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 6

Similar Datasets

ilAcrLepo1

Project description:Acronicta leporina (the miller) genome assembly, ilAcrLepo1

| PRJEB57243 | ENA

ilAcrLepo

Project description:Acronicta leporina (the miller), genomic and transcriptomic data

| PRJEB56405 | ENA

ilAcrLepo1 alternate haplotype

Project description:Acronicta leporina (the miller) genome assembly, ilAcrLepo1, alternate haplotype

| PRJEB57242 | ENA

Acronicta leporina

Project description:Acronicta leporina overview

| PRJNA898482 | ENA

Spatial immunophenotypes orchestrate prognosis in triple negative breast cancer with Miller Payne grade 4

Project description:Some triple-negative breast cancer (TNBC) patients evaluated as Miller-Payne 4 with ypN0 after neoadjuvant chemotherapy (NACT) who have better prognosis should avoid escalation of therapy. We aim to identify these patients through evaluating pretherapeutic spatial distributions of immunophenotypes. Our retrospective study in patients with TNBC assessed as Miller-Payne grade 4/5 with ypN0 showed that Miller-Payne 4 with ypN0 group had poorer 5-year disease-free survival (DFS, 63.8% vs 83.0%, p=0.003) and the 5-year overall survival (OS, 71.0% vs 85.5%, p=0.007) than Miller-Payne 5 with ypN0 group. High TILs were significantly associated with better DFS and OS in patients with Miller-Payne 4 and ypN0 (both p=0.016). Spatially, detected by multiplexed ion beam imaging by time of flight combined with proteomics, tumors assessed as Miller-Payne 4 and ypN0 with good prognosis exhibited an inflamed phenotype, with dominant CD8+ T cells on tumor center, few scattered CD68+ myeloid-derived cells far away from T cells, and deposit of increased activated molecules of lymphocyte. While those with poor prognosis presented excluded phenotype, with few CD8+ T cells restricted to invasive margin and a high density of CD14+CD68+CD11c+ myeloid cells. A good classifier model based on 29 spatial immunophenotypes was established by the random forest algorithm (AUC=0.975), for identifying patients with Miller-Payne 4 and ypN0 who had favorable prognosis. We also observed similar signatures in patients with Miller-Payne 5 and ypN0. Taken together, spatial immunophenotypes may assess the prognosis in TNBC patients with Miller-Payne 4 and ypN0 after NACT.

2023-07-08 | PXD029186 | Pride

ilAcrPsix

Project description:Acronicta psi

| PRJEB55133 | ENA

Oestromyia leporina

Project description:Oestromyia leporina Raw sequence reads

| PRJNA631151 | ENA

Acronicta alni

Project description:Acronicta alni overview

| PRJNA1112522 | ENA

Acronicta psi

Project description:Acronicta psi overview